103 related articles for article (PubMed ID: 28620779)
1. The cost of a patient activation intervention for achieving successful outcomes: results from the PAADRN randomized controlled trial.
Wolinsky FD; Hall SF; Lou Y; Edmonds SW; Saag KG; Roblin DW; Wright NC; Jones MP; Cram P; ; Curtis JR; Morgan SL; Schlechte JA; Williams JH; Zelman DJ
Osteoporos Int; 2017 Oct; 28(10):3061-3066. PubMed ID: 28620779
[TBL] [Abstract][Full Text] [Related]
2. The effects of a patient activation intervention on smoking and excessive drinking cessations: results from the PAADRN randomized controlled trial.
Wolinsky FD; Lou Y; Edmonds SW; Saag KG; Roblin DW; Wright NC; Jones MP; Cram P;
Osteoporos Int; 2017 Oct; 28(10):3055-3060. PubMed ID: 28573377
[TBL] [Abstract][Full Text] [Related]
3. Effects of a DXA result letter on satisfaction, quality of life, and osteoporosis knowledge: a randomized controlled trial.
Edmonds SW; Cram P; Lou Y; Jones MP; Roblin DW; Saag KG; Wright NC; Wolinsky FD;
BMC Musculoskelet Disord; 2016 Aug; 17(1):369. PubMed ID: 27562713
[TBL] [Abstract][Full Text] [Related]
4. Diet and exercise changes following bone densitometry in the Patient Activation After DXA Result Notification (PAADRN) study.
Roblin DW; Cram P; Lou Y; Edmonds SW; Hall SF; Jones MP; Saag KG; Wright NC; Wolinsky FD;
Arch Osteoporos; 2018 Jan; 13(1):4. PubMed ID: 29307094
[TBL] [Abstract][Full Text] [Related]
5. Patient-activation and guideline-concordant pharmacological treatment after bone density testing: the PAADRN randomized controlled trial.
Cram P; Wolinsky FD; Lou Y; Edmonds SW; Hall SF; Roblin DW; Wright NC; Jones MP; Saag KG;
Osteoporos Int; 2016 Dec; 27(12):3513-3524. PubMed ID: 27363400
[TBL] [Abstract][Full Text] [Related]
6. The prevalence of overtreatment of osteoporosis: results from the PAADRN trial.
Hall SF; Wright NC; Wolinsky FD; Lou Y; Edmonds S; Roblin D; Jones M; Saag K; Cram P
Arch Osteoporos; 2018 Sep; 13(1):103. PubMed ID: 30267162
[TBL] [Abstract][Full Text] [Related]
7. The PAADRN study: a design for a randomized controlled practical clinical trial to improve bone health.
Edmonds SW; Wolinsky FD; Christensen AJ; Lu X; Jones MP; Roblin DW; Saag KG; Cram P;
Contemp Clin Trials; 2013 Jan; 34(1):90-100. PubMed ID: 23085132
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a "Just-in-Time" Nurse Consultation on Bone Health: A Pilot Randomized Controlled Trial.
Roblin DW; Zelman D; Plummer S; Robinson BE; Lou Y; Edmonds SW; Wolinsky FD; Saag KG; Cram P
Perm J; 2017; 21():16-112. PubMed ID: 28746019
[TBL] [Abstract][Full Text] [Related]
9. Activating Patients With a Tailored Bone Density Test Results Letter and Educational Brochure: the PAADRN Randomized Controlled Trial.
Wolinsky FD; Lou Y; Edmonds SW; Hall SF; Jones MP; Wright NC; Saag KG; Cram P; Roblin DW;
J Clin Densitom; 2017; 20(4):464-471. PubMed ID: 27647261
[TBL] [Abstract][Full Text] [Related]
10. Sex differences in osteoporosis self-efficacy among community-residing older adults presenting for DXA.
Solimeo SL; Nguyen VT; Edmonds SW; Lou Y; Roblin DW; Saag KG; Cram P; Wolinsky FD
Osteoporos Int; 2019 May; 30(5):1033-1041. PubMed ID: 30701343
[TBL] [Abstract][Full Text] [Related]
11. Racial Differences and Disparities in Osteoporosis-related Bone Health: Results From the PAADRN Randomized Controlled Trial.
Cram P; Saag KG; Lou Y; Edmonds SW; Hall SF; Roblin DW; Wright NC; Jones MP; Wolinsky FD;
Med Care; 2017 Jun; 55(6):561-568. PubMed ID: 28288074
[TBL] [Abstract][Full Text] [Related]
12. A randomized trial of a mailed intervention and self-scheduling to improve osteoporosis screening in postmenopausal women.
Warriner AH; Outman RC; Kitchin E; Chen L; Morgan S; Saag KG; Curtis JR
J Bone Miner Res; 2012 Dec; 27(12):2603-10. PubMed ID: 22836812
[TBL] [Abstract][Full Text] [Related]
13. Validity, reliability, and responsiveness to change of the "Osteoporosis and You" knowledge scale.
Nguyen VT; Edmonds SW; Lou Y; Roblin DW; Saag KG; Cram P; Wolinsky FD
Osteoporos Int; 2017 Dec; 28(12):3379-3388. PubMed ID: 28879445
[TBL] [Abstract][Full Text] [Related]
14. Metasynthesis of Patient Attitudes Toward Bone Densitometry.
Seaman AT; Steffen M; Doo T; Healy HS; Solimeo SL
J Gen Intern Med; 2018 Oct; 33(10):1796-1804. PubMed ID: 30054881
[TBL] [Abstract][Full Text] [Related]
15. Persistence, reproducibility, and cost-effectiveness of an intervention to improve the quality of osteoporosis care after a fracture of the wrist: results of a controlled trial.
Majumdar SR; Johnson JA; Lier DA; Russell AS; Hanley DA; Blitz S; Steiner IP; Maksymowych WP; Morrish DW; Holroyd BR; Rowe BH
Osteoporos Int; 2007 Mar; 18(3):261-70. PubMed ID: 17086470
[TBL] [Abstract][Full Text] [Related]
16. A randomized trial to assess the impact of direct reporting of DXA scan results to patients on quality of osteoporosis care.
Cram P; Schlechte J; Christensen A
J Clin Densitom; 2006; 9(4):393-8. PubMed ID: 17097523
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of two inexpensive postfracture osteoporosis interventions: results of a randomized trial.
Majumdar SR; Lier DA; Leslie WD
J Clin Endocrinol Metab; 2013 May; 98(5):1991-2000. PubMed ID: 23596140
[TBL] [Abstract][Full Text] [Related]
18. Effect of self-referral on bone mineral density testing and osteoporosis treatment.
Warriner AH; Outman RC; Feldstein AC; Roblin DW; Allison JJ; Curtis JR; Redden DT; Rix MM; Robinson BE; Rosales AG; Safford MM; Saag KG
Med Care; 2014 Aug; 52(8):743-50. PubMed ID: 24984211
[TBL] [Abstract][Full Text] [Related]
19. Primary prevention of osteoporosis: mass screening scenario or prescreening with questionnaires? An economic perspective.
Richy F; Ethgen O; Bruyere O; Mawet A; Reginster JY
J Bone Miner Res; 2004 Dec; 19(12):1955-60. PubMed ID: 15537437
[TBL] [Abstract][Full Text] [Related]
20. Osteoporosis pharmacotherapy following bone densitometry: importance of patient beliefs and understanding of DXA results.
Brask-Lindemann D; Cadarette SM; Eskildsen P; Abrahamsen B
Osteoporos Int; 2011 May; 22(5):1493-501. PubMed ID: 20683704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
